{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:07:53Z","timestamp":1777950473449,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1127792"],"award-info":[{"award-number":["GNT1127792"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115238","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T12:43:24Z","timestamp":1690893804000},"page":"115238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Novel AT2R agonist, \u03b2-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-6765","authenticated-orcid":false,"given":"Mandy","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Ferens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iresha","family":"Spizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate M.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Del Borgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9965-4722","authenticated-orcid":false,"given":"Ketav","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-4064","authenticated-orcid":false,"given":"Marie-Isabel","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxue Helena","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrishan S.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey A.","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Widdop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib1","doi-asserted-by":"crossref","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115238_bib2","unstructured":"WHO. Diabetes [Internet]. 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"10.1016\/j.biopha.2023.115238_bib3","doi-asserted-by":"crossref","unstructured":"Petrie J.R., Guzik T.J., Touyz R.M.Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol [Internet]. 2017\/12\/11. 2018 May;34(5):575\u201384. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29459239.","DOI":"10.1016\/j.cjca.2017.12.005"},{"key":"10.1016\/j.biopha.2023.115238_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin-angiotensin-aldosterone system and its therapeutic targets","volume":"186","author":"Mirabito Colafella","year":"2019","journal-title":"Exp. Eye Res"},{"key":"10.1016\/j.biopha.2023.115238_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharm. Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115238_bib6","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2023.115238_bib7","first-page":"787","article-title":"Sim\u00f5es e Silva AC. The renin-angiotensin system and diabetes: an update","volume":"4","author":"Ribeiro-Oliveira","year":"2008","journal-title":"Vasc. Health Risk Manag"},{"issue":"4","key":"10.1016\/j.biopha.2023.115238_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11897-017-0343-y","article-title":"From inflammation to fibrosis\u2014molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities","volume":"14","author":"Suthahar","year":"2017","journal-title":"Curr. Heart Fail Rep."},{"issue":"6958","key":"10.1016\/j.biopha.2023.115238_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"and Smad-independent pathways in TGF-\u03b2 family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2023.115238_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115238_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-\u03b2 signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.biopha.2023.115238_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.biopha.2023.115238_bib13","doi-asserted-by":"crossref","first-page":"F1123","DOI":"10.1152\/ajprenal.00247.2014","article-title":"Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats","volume":"307","author":"Castoldi","year":"2014","journal-title":"Am. J. Physiol. -Ren. Physiol. [Internet]"},{"issue":"3","key":"10.1016\/j.biopha.2023.115238_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.113.02522","article-title":"Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1\/matrix metalloproteinase 9 axis and transforming growth factor \u03b21 in the rat heart","volume":"63","author":"Lauer","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2023.115238_bib15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.115.05204","article-title":"AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy","volume":"65","author":"Koulis","year":"2015","journal-title":"Hypertens. [Internet]"},{"issue":"4","key":"10.1016\/j.biopha.2023.115238_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13063","article-title":"Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo","volume":"173","author":"Sampson","year":"2016","journal-title":"Br. J. Pharm."},{"issue":"24","key":"10.1016\/j.biopha.2023.115238_bib17","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","article-title":"Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?","volume":"118","author":"Kaschina","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2023.115238_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-018-1220-1","article-title":"Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats","volume":"56","author":"Castoldi","year":"2019","journal-title":"Acta Diabetol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115238_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/CS20150077","article-title":"\u03b2-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats","volume":"129","author":"Del Borgo","year":"2015","journal-title":"Clin. Sci. [Internet]"},{"issue":"7","key":"10.1016\/j.biopha.2023.115238_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1042\/CS20200153","article-title":"Renal functional effects of the highly selective AT2R agonist, \u03b2-Pro7 Ang III, in normotensive rats","volume":"134","author":"Krause","year":"2020","journal-title":"Clin. Sci."},{"issue":"22","key":"10.1016\/j.biopha.2023.115238_bib22","doi-asserted-by":"crossref","first-page":"14039","DOI":"10.3390\/ijms232214039","article-title":"The Novel AT2 receptor agonist \u03b2-Pro7-angiii exerts cardiac and renal anti-fibrotic and anti-inflammatory effects in high salt-fed mice","volume":"23","author":"Wang","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2023.115238_bib23","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.34067\/KID.0002722021","article-title":"Relaxin attenuates organ fibrosis via an angiotensin type 2 receptor mechanism in aged hypertensive female rats","volume":"2","author":"Barsha","year":"2021","journal-title":"Kidney360"},{"issue":"6","key":"10.1016\/j.biopha.2023.115238_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.carpath.2009.07.003","article-title":"Chronic type 1 diabetes in spontaneously hypertensive rats leads to exacerbated cardiac fibrosis","volume":"19","author":"Black","year":"2010","journal-title":"Cardiovasc. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acsptsci.9b00095","article-title":"Serelaxin and the AT2 receptor agonist CGP42112 evoked a similar, nonadditive, cardiac antifibrotic effect in high salt-fed mice that were refractory to candesartan cilexetil","volume":"3","author":"Wang","year":"2020","journal-title":"ACS Pharm. Transl. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.115238_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0b013e3283311ba1","article-title":"Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage","volume":"27","author":"Gelosa","year":"2009","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.biopha.2023.115238_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.110.164202","article-title":"Siragy HM. Angiotensin AT\u2082 receptor stimulation inhibits early renal inflammation in renovascular hypertension","volume":"57","author":"Matavelli","year":"2011","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.biopha.2023.115238_bib28","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3390\/cells10102640","article-title":"BMP-7 attenuates inflammation-induced pyroptosis and improves cardiac repair in diabetic cardiomyopathy","volume":"10","author":"Elmadbouh","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biopha.2023.115238_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2249.2006.03229.x","article-title":"Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes","volume":"146","author":"Hatanaka","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115238_bib30","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.00393.2016","article-title":"Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-\u03baB-TNF-\u03b1 and TGF-\u03b21-MAPK-fibronectin pathways","volume":"313","author":"Malik","year":"2017","journal-title":"Am. J. Physiol. -Ren. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115238_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.bbrc.2017.04.134","article-title":"Compound 21 and Telmisartan combination mitigates type 2 diabetic nephropathy through amelioration of caspase mediated apoptosis","volume":"487","author":"Pandey","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"issue":"3","key":"10.1016\/j.biopha.2023.115238_bib32","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00616.2010","article-title":"Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats","volume":"300","author":"Sabuhi","year":"2011","journal-title":"Am. J. Physiol. -Ren. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115238_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-016-3977-5","article-title":"The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis","volume":"59","author":"Chow","year":"2016","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib34","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"issue":"7","key":"10.1016\/j.biopha.2023.115238_bib35","doi-asserted-by":"crossref","first-page":"H1036","DOI":"10.1152\/ajpheart.00340.2014","article-title":"Cardiac-specific suppression of NF-\u03baB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system","volume":"307","author":"Thomas","year":"2014","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115238_bib36","doi-asserted-by":"crossref","first-page":"H1712","DOI":"10.1152\/ajpheart.00124.2004","article-title":"NF-\u03baB activation is required for the development of cardiac hypertrophy in vivo","volume":"287","author":"Li","year":"2004","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-8-35","article-title":"Curcumin ameliorates macrophage infiltration by inhibiting NF-\u03baB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy","volume":"8","author":"Soetikno","year":"2011","journal-title":"Nutr. Metab. (Lond. )"},{"issue":"4","key":"10.1016\/j.biopha.2023.115238_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/S1734-1140(09)70111-2","article-title":"Role of NF-\u03baB in the pathogenesis of diabetes and its associated complications","volume":"61","author":"Patel","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2023.115238_bib39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1440-1681.1986.tb02394.x","article-title":"Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotocin diabetic rat","volume":"13","author":"Cooper","year":"1986","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ajh\/1.1.5","article-title":"Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat","volume":"1","author":"Cooper","year":"1988","journal-title":"Am. J. Hypertens."},{"issue":"7","key":"10.1016\/j.biopha.2023.115238_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006260","article-title":"Type 2 diabetes mellitus and impact of heart failure on prognosis compared to other cardiovascular diseases","volume":"13","author":"Zareini","year":"2020","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib42","doi-asserted-by":"crossref","first-page":"17950","DOI":"10.1038\/s41598-022-22932-4","article-title":"The significance of chronic kidney disease, heart failure and cardiovascular disease for mortality in type 1 diabetes: nationwide observational study","volume":"12","author":"Eliasson","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115238_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100739","article-title":"Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years","volume":"32","author":"Lawson","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.biopha.2023.115238_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.115.06881","article-title":"Angiotensin II type 2\u2013receptor agonist c21 reduces proteinuria and oxidative stress in kidney of high-salt\u2013fed obese zucker rats","volume":"67","author":"Patel","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.115238_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114556","article-title":"The protective effects of a novel AT2 receptor agonist, \u03b2-Pro7Ang III in ischemia-reperfusion kidney injury","volume":"161","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.biopha.2023.115238_bib46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10557-005-5059-7","article-title":"Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats","volume":"18","author":"Nagai","year":"2004","journal-title":"Cardiovasc Drugs Ther."},{"issue":"6","key":"10.1016\/j.biopha.2023.115238_bib47","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.25.6.1252","article-title":"Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats","volume":"25","author":"Kim","year":"1995","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2023.115238_bib48","first-page":"466","article-title":"Losartan reduces myocardial interstitial fibrosis in diabetic cardiomyopathy rats by inhibiting JAK\/STAT signaling pathway","volume":"8","author":"Wang","year":"2015","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115238_bib49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/HYPERTENSIONAHA.114.03594","article-title":"Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease","volume":"64","author":"Samuel","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.115238_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114370","article-title":"The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy","volume":"160","author":"Alam","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223010296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:28:41Z","timestamp":1777879721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223010296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"alternative-id":["S0753332223010296"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115238","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel AT2R agonist, \u03b2-Pro7Ang III, is cardio- and vaso-protective in diabetic spontaneously hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115238"}}